While not new, VITT emerged as a new disease following adenovirus vector-based Oxford-AstraZeneca vaccine — sold as Covishield in India and Vaxzevria in Europe — at the height of the Covid pandemic in 2021
AstraZeneca Covid Vax Linked to Another Rare Fatal Blood Clotting Disorder
- Post author:
- Post published:May 16, 2024
- Post category:Blog